Therapeutic blockade of tumour necrosis factor alpha (TNF) has emerged as an effective treatment in immune-mediated inflammatory diseases (IMID) such as rheumatoid arthritis, ankylosing spondylitis, Crohn's disease and psoriatic arthritis. The gene discussed is TNF; the disease is rheumatoid arthritis.